Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 7/29/2025LENZ Moves Toward Approval in China with LNZ100 Submission
  • 7/29/2025Bayer Files HER2+ Lung Cancer Drug in China
  • 7/28/2025Antengene's XPOVIO® Wins Third Approval in China for Multiple Myeloma
  • 7/28/2025China Medical System Gains NMPA Acceptance for Alzheimer's Drug ZUNVEY...
  • 7/28/2025Pierre Fabre Scores China Approval for Braftovi + Cetuximab in BRAF V6...
  • 7/28/2025TargetRx Showcases Breakthrough Allosteric BCR::ABL1 Inhibitor for Res...
  • 7/28/2025China Approves BMS's Opdivo + Yervoy Combo for PD-L1 Positive mNSCLC
  • 7/28/2025SystImmune Files First ARC IND as ADC Pipeline Hits Double Digits
  • 7/26/2025China Leads Global Expansion in Clinical Trial Volume in Q2 2025: Glob...
  • 7/25/2025Yangtze River Pharma's Tunodafil Wins NMPA Nod
  • 7/25/2025Eisai's Lenvatinib Secures NMPA Approval in China
  • 7/25/2025AusperBio Advances AHB‑137 to Phase 3 After Green Light from China NM...
  • 7/24/2025Kelun-Biotech Initiates Phase I Trial of SKB107
  • 7/24/2025Cascade Pharma's CS0159 Wins FDA Breakthrough For PBC
  • 7/23/2025China-Singapore Nanovaccine Prevents Cancer Recurrence in Animals
  • 7/23/2025DualityBio's DB‑1310 Earns FDA Fast‑Track for EGFR‑Mutated Lung Can...
  • 7/23/2025Qilu Initiates Global Phase III Trial of QLS31905 for Pancreatic Cance...
  • 7/23/2025Kelun‑Biotech Launches Phase I Trial of SKB107 in China to Tackle Bon...
  • 7/22/2025Livzon's Dual Inhibitor LZM‑012 Positive in Global Phase III Psoriasi...
  • 7/22/2025Cloudbreak Pharma Reports Positive Phase 2 Outcomes for CBT‑004
  • 7/22/2025Simcere Zaiming Secures U.S. FDA Approval for IND of FGFR2b-Targeted A...
  • 7/22/2025AusperBio Cleared to Begin Phase III Trial of AHB-137 for Chronic HepB...
  • 7/22/2025Huadong Subsidiary Reports Strong Phase III Results for Roflumilast Cr...
  • 7/22/2025Innovent Secures IND for Oral GLP‑1 Agonist IBI3032 as Mazdutide Hits...
  • 7/18/2025SKBio Wins Chinese Clinical Trial Approval for GBP410
  • 7/18/2025Hengrui's SHR‑A1904 Emerges as Promising New Weapon Against Advanced ...
  • 7/18/2025China Approves First Homegrown Oral Anti‑Influenza Drug by Zenshine P...
  • 7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...
  • 7/18/2025China Approves Nation's First Recombinant Human Albumin Injection Deri...
  • 7/17/2025China Accepts Amgen and ONC Marketing Submission for Imdelltra in ES-S...
  • Page:1/17 Total number of articles:502: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group